Skip to main content
Log in

Mitral regurgitation in chronic heart failure: More questions than answers?

  • Published:
Current Cardiology Reports Aims and scope Submit manuscript

Abstract

The presence, implications, and approach to mitral valvular disease in the setting of a cardiomyopathy has recently become a focal issue for discussion. Although recent evidence suggests that mitral regurgitation confers a poor prognosis in heart failure, the true prevalence of mitral regurgitation as well as its pathogenic contribution to prognosis in heart failure remains uncertain. Whereas angiotensin-converting enzyme inhibitors have not been demonstrated to favorably alter mitral regurgitation, treatment with β-blockers or cardiac resynchronization therapy has been shown to induce regression of ventricular dilation, with consequent decrease in mitral regurgitation. Surgical valve reconstruction by undersized ring annuloplasty appears promising, but optimal results require skilled surgical expertise. Even in highly experienced hands, intermediate outcomes appear to be inferior to those of cardiac transplantation. Percutaneous mitral valve repair remains an investigational procedure that warrants further clinical research.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References and Recommended Reading

  1. Mehra MR, Uber PA, Francis GS: Heart failure therapy at a crossroad: are there limits to the neurohormonal model?. J Am Coll Cardiol 2003, 41:1606–1610.

    Article  PubMed  Google Scholar 

  2. Robbins JD, Maniar PB, Cotts W, et al.: Prevalence and severity of mitral regurgitation in chronic systolic heart failure. Am J Cardiol 2003, 91:360–362.

    Article  PubMed  Google Scholar 

  3. Trichon BH, Felker GM, Shaw LK, et al.: Relation of frequency and severity of mitral regurgitation to survival among patients with left ventricular systolic dysfunction and heart failure. Am J Cardiol 2003, 91:538–543.

    Article  PubMed  Google Scholar 

  4. Koelling TM, Aaronson KD, Cody RJ, et al.: Prognostic significance of mitral regurgitation and tricuspid regurgitation in patients with left ventricular systolic dysfunction. Am Heart J 2002, 144:524–529.

    Article  PubMed  Google Scholar 

  5. Varadarajan P, Pai RG: Prognosis of congestive heart failure in patients with normal versus reduced ejection fractions: results from a cohort of 2,258 hospitalized patients. J Card Fail 2003, 9:107–112.

    Article  PubMed  Google Scholar 

  6. Karagiannis SE, Karatasakis GT, Koutsogiannis N, et al.: Increased distance between mitral valve coaptation point and mitral annular plane: significance and correlations in patients with heart failure. Heart 2003, 89:1174–1178. This paper seeks to define the predominant etiology of loss of coaptation in the mitral leaflets by discussing alterations in the apparatus in heart failure.

    Article  PubMed  CAS  Google Scholar 

  7. Nielsen SL, Nygaard H, Mandrup L, et al.: Mechanism of incomplete mitral leaflet coaptation--interaction of chordal restraint and changes in mitral leaflet coaptation geometry. Insight from in vitro validation of the premise of force equilibrium. J Biomech Eng 2002, 124:596–608.

    Article  PubMed  Google Scholar 

  8. Di Donato M, Sabatier M, Dor V, et al.: Effects of the Dor procedure on left ventricular dimension and shape and geometric correlates of mitral regurgitation one year after surgery. J Thorac Cardiovasc Surg 2001, 121:91–96. An important observation, this study links geometric reconfiguration with the development of MR in follow-up after infarct exclusion surgery.

    Article  PubMed  Google Scholar 

  9. Lowes BD, Gill EA, Abraham WT, et al.: Effects of carvedilol on left ventricular mass, chamber geometry, and mitral regurgitation in chronic heart failure. Am J Cardiol 1999, 83:1201–1205.

    Article  PubMed  CAS  Google Scholar 

  10. Nemoto S, Hamawaki M, De Freitas G, Carabello BA: Differential effects of the angiotensin-converting enzyme inhibitor lisinopril versus the beta-adrenergic receptor blocker atenolol on hemodynamics and left ventricular contractile function in experimental mitral regurgitation. J Am Coll Cardiol 2002, 40:149–154.

    Article  PubMed  CAS  Google Scholar 

  11. Capomolla S, Febo O, Gnemmi M, et al.: Beta-blockade therapy in chronic heart failure: diastolic function and mitral regurgitation improvement by carvedilol. Am Heart J 2000, 139:596–608.

    Article  PubMed  CAS  Google Scholar 

  12. Saxon LA, Ellenbogen KA: Resynchronization therapy for the treatment of heart failure. Circulation 2003, 108:1044–1048.

    Article  PubMed  Google Scholar 

  13. Breithardt OA, Sinha AM, Schwammenthal E, et al.: Acute effects of cardiac resynchronization therapy on functional mitral regurgitation in advanced systolic heart failure. J Am Coll Cardiol 2003, 41:765–770.

    Article  PubMed  Google Scholar 

  14. St. John Sutton MG, Plappert T, Abraham WT, et al., for the Clinical Evaluation (MIRACLE) Study Group: Effect of cardiac resynchronization therapy on left ventricular size and function in chronic heart failure. Circulation 2003, 107:1985–1990. This investigation demonstrates the benefits of biventricular pacing on cardiac remodeling and in particular emphasizes that this technique can serve to ameliorate MR by decreasing ventricular asynergy.

    Article  PubMed  Google Scholar 

  15. Romano MA, Bolling SF: Mitral valve repair as an alternative treatment for heart failure patients. Heart Fail Monit 2003, 4:7–12. The authors highlight their unique high-volume experience with surgical mitral valve repair in severe heart failure. This experience demonstrates the feasibility of this approach in selected patients but also emphasizes the importance of operator experience in determining optimal outcomes.

    PubMed  Google Scholar 

  16. Bishay ES, McCarthy PM, Cosgrove DM, et al. Mitral valve surgery in patients with severe left ventricular dysfunction. Eur J Cardiothorac Surg 2000, 17:213–221.

    Article  PubMed  CAS  Google Scholar 

  17. Kwan J, Shiota T, Agler DA, et al.: Geometric differences of the mitral apparatus between ischemic and dilated cardiomyopathy with significant mitral regurgitation: real-time three-dimensional echocardiography study. Circulation 2003, 107:1135–1140.

    Article  PubMed  Google Scholar 

  18. Enriquez-Sarano M, Schaff HV, Frye RL: Mitral regurgitation: what causes the leakage is fundamental to the outcome of valve repair. Circulation 2003, 108:253–256.

    Article  PubMed  Google Scholar 

  19. Flameng W, Herijgers P, Bogaerts K: Recurrence of mitral valve regurgitation after mitral valve repair in degenerative valve disease. Circulation 2003, 107:1609–1613.

    Article  PubMed  Google Scholar 

  20. Kaye DM, Byrne M, Alferness C, Power J: Feasibility and shortterm efficacy of percutaneous mitral annular reduction for the therapy of heart failure-induced mitral regurgitation. Circulation 2003, 108:1795–1797.

    Article  PubMed  Google Scholar 

  21. Liddicoat JR, Mac Neill BD, Gillinov AM, et al.: Percutaneous mitral valve repair: a feasibility study in an ovine model of acute ischemic mitral regurgitation. Catheter Cardiovasc Interv 2003, 60:410–416.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Mehra, M.R., Gheorghiade, M. & Bonow, R.O. Mitral regurgitation in chronic heart failure: More questions than answers?. Curr Cardiol Rep 6, 96–99 (2004). https://doi.org/10.1007/s11886-004-0005-z

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11886-004-0005-z

Keywords

Navigation